RedHill Biopharma (RDHL) Profit After Tax (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly Profit After Tax of $101.2 million for Q2 2023, up 764.51% year-over-year from $11.7 million in Q2 2022, and up 301.51% quarter-over-quarter from -$50.2 million in Q1 2023.
RedHill Biopharma (RDHL) Profit After Tax (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Profit After Tax for 12 consecutive years, with $101.2 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Profit After Tax rose 764.51% year-over-year to $101.2 million; the TTM figure through Jun 2023 stood at -$52.9 million (up 54.97% YoY), while the FY2025 annual figure was -$8.1 million, down 2344.44% from the prior year.
- Profit After Tax climbed to $101.2 million in Q2 2023 per RDHL's latest filing, from -$50.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $101.2 million in Q2 2023 and bottomed at -$171.1 million in Q4 2021.
- Historically, Profit After Tax has averaged $3666.7 across 5 years, with a median of $16.6 million in 2020.
- Annual changes were most pronounced in 2021 — Profit After Tax plunged 803.28% — and 2023, when it soared 764.51%.
- RedHill Biopharma's Profit After Tax stood at $11.7 million in 2019, then surged by 108.12% to $24.3 million in 2020, then slumped by 803.28% to -$171.1 million in 2021, then climbed by 18.41% to -$139.6 million in 2022, then soared by 172.52% to $101.2 million in 2023.
- Business Quant data shows RDHL's Profit After Tax at $101.2 million in Q2 2023, -$50.2 million in Q1 2023, and -$139.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 101.24 Mn |
| Mar 31, 2023 | -50.24 Mn |
| Dec 31, 2022 | -139.61 Mn |
| Sep 30, 2022 | 35.70 Mn |
| Jun 30, 2022 | 11.71 Mn |
| Mar 31, 2022 | 20.53 Mn |
| Dec 31, 2021 | -171.12 Mn |
| Sep 30, 2021 | 21.39 Mn |
| Jun 30, 2021 | 29.12 Mn |
| Mar 31, 2021 | 22.86 Mn |
| Dec 31, 2020 | 24.33 Mn |
| Sep 30, 2020 | 18.64 Mn |
| Jun 30, 2020 | 16.05 Mn |
| Mar 31, 2020 | 17.16 Mn |
| Dec 31, 2019 | 11.69 Mn |
| Sep 30, 2019 | 9.84 Mn |
| Jun 30, 2019 | 10.91 Mn |
| Mar 31, 2019 | 9.87 Mn |
| Dec 31, 2018 | 7.68 Mn |
| Sep 30, 2018 | 10.08 Mn |